AliveCor QT Service vs Study Watch
AI Verdict
Choose AliveCor QT Service if…
Choose AliveCor QT Service if your primary need is rapid, accurate, and on-demand QT/QTc interval measurement from 6-Lead ECGs to inform immediate medication prescribing decisions and enhance cardiac safety. This cloud-based Software as a Medical Device (SaMD) is ideal for healthcare professionals requiring instant, AI-powered analysis for clinical decision-making in a prescription-only setting.
View AliveCor QT Service →Choose Study Watch if…
Choose Verily Study Watch if your objective is continuous, long-term physiological data collection for clinical research studies requiring a multi-sensor wearable device. This prescription-only tool is best suited for researchers needing to gather comprehensive data like ECG, heart rate, and movement over extended periods for analysis within a dedicated cloud platform.
View Study Watch →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AliveCor QT Service | Study Watch |
|---|---|---|
| Pricing | Varies by product and service, with subscription options available. | Unknown |
| Deployment | Mobile app, cloud-based platform, EHR integration. | The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AliveCor QT ServiceTool A (AliveCor QT Service) offers a more direct and immediate clinical workflow for healthcare professionals, providing instant QT measurements within an integrated ecosystem (KardiaStation/KardiaPro) for critical decision-making. Tool B (Verily Study Watch), while collecting valuable data, is primarily designed for continuous monitoring in research, which involves a different, often more complex, user experience for both patients (wearing the device) and researchers (data analysis).
Clinical Value
AliveCor QT ServiceTool A offers immediate and direct clinical value by providing critical cardiac safety measurements (QT/QTc) that directly inform medication prescribing decisions and help prevent life-threatening arrhythmias in a clinical setting. Tool B's value is more focused on enabling comprehensive data collection for clinical research, which is an upstream contribution to clinical care, rather than immediate, specific clinical decision support in routine practice.
Pricing & Value
TieBoth tools lack publicly available pricing information, making a direct comparison of their 'pricing & value' impossible. While both offer significant value in their respective domainsu2014direct clinical decision support for Tool A and research enablement for Tool Bu2014without cost details, it is not possible to determine which offers better overall value.
Enterprise Readiness
AliveCor QT ServiceTool A explicitly highlights an API for integration with a wide range of enterprise systems (EHR, SDK, CRM, EDC, PSP), demonstrating a clear focus on seamless integration into existing healthcare IT infrastructures. While Tool B is used in enterprise research settings, its JSON does not detail similar integration capabilities, and the mention of an ongoing lawsuit, even if denied, introduces a potential concern for enterprise adoption.
Innovation
Study WatchTool B demonstrates broader innovation by offering a multi-sensor wearable for continuous, non-invasive physiological monitoring, collecting diverse data types (ECG, heart rate, movement, electrodermal activity) over extended periods for clinical research. This represents a more comprehensive and foundational approach to data acquisition for precision health compared to Tool A's focused AI application for a specific ECG measurement.
Support & Docs
Study WatchVerily provides a more explicitly organized and comprehensive support portal directly referencing the Study Watch with user manuals, regulatory documents, and resources for its associated data platforms (Data Workbench, Site CTMS). While AliveCor offers a 'Resource Hub' and device manuals, Verily's support structure appears more tailored and readily accessible for its specific product and research ecosystem.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AliveCor QT Service | Study Watch |
|---|---|---|
| Name | AliveCor QT Service | Study Watch |
| Company | AliveCor | Verily Life Sciences |
| Primary Function/Purpose | A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions. | A prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform. |
| Device Type | Cloud-based Software as a Medical Device (SaMD) | Sensor-based wearable device |
| Key Measurement/Data Collected | Measures QT and QTc intervals (Bazett's and Fridericia's formulas) from AliveCor 6-Lead ambulatory ECG devices. | ECG, heart rate, electrodermal activity, inertial movements, on-demand single-channel ECG, irregular pulse monitor. |
Videos
Demos, reviews, and walkthroughs featuring AliveCor QT Service and Study Watch.
Frequently Asked Questions
More Comparisons
More matchups featuring AliveCor QT Service or Study Watch
Backers
Who funded each tool's parent company.